Analyst
Equibles does not estimate personal net worth.
Dave Roberts has spoken on 2 earnings calls and 5 other investor events across 1 company, most recently for Lemaitre Vascular Inc on September 22, 2026. The companies whose calls Dave Roberts spoke on are classified in the Healthcare sector.
“It is something we think about on a long-term basis, but I think we still have a long way to go in the US to rationalize and improve our supply of cardiac tissue, especially here.”
“We've put out two or three term sheets so far this year. The hunting ground remains the same of open vascular, where there are a couple dozen targets, and cardiac surgery, which, of course, is about 12% of the revenue.”
“We've put out two or three term sheets so far this year. The hunting ground remains the same of open vascular, where there are a couple dozen targets, and cardiac surgery, which, of course, is about 12% of the revenue.”
“We've put out two or three term sheets so far this year. The hunting ground remains the same of open vascular, where there are a couple dozen targets, and cardiac surgery, which, of course, is about 12% of the revenue.”
“We've put out two or three term sheets so far this year. The hunting ground remains the same of open vascular, where there are a couple dozen targets, and cardiac surgery, which, of course, is about 12% of the revenue.”
Medical Instruments & Supplies · Healthcare
